WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

Dr. Ibrahim Sinan Abdulfattah* and Professor Dr. Khitam Razzaq Kadhim

ABSTRACT

Introduction: Lymphoma considered as one of blood malignancies that progress from lymphocytes. Moreover, identified as lymphoid neoplasms, have variable clinical, histology, immunophenotypes, and genetic anomalies. The aim of study is to detect the frequency of lymphoma and to correlate with clinicopathological parameters including (age, gender, site and subtype). Method: A retrospective study was performed on 190 patients with lymphoma, from January 2018 to December 2021 at the departments of pathology in Teaching laboratories and Ghazi Al Harriri hospital, Medical city, Baghdad, Iraq. Clinicopathological parameters: Age, gender, site, subtype. Results: 100 cases of Hodgkin lymphoma and 90 cases of non Hodgkin lymphoma, the mean age of patients with Hodgkin lymphoma (HL) 27 ± 16 years old, the mean age of patients with Non Hodgkin lymphoma (NHL) 48 ± 21 years old. distribution of patients have (HL) according to age groups, (28%) of patients at age group 11-20 years old while (23%) of patients at age group 21-30 years old. Distribution of patients have (NHL) according to age groups, (35.56%) of patients at age group >60 years old while (20%) of patients at age group 41-50 years old. There is significant association between HL, NHL and (age groups of patients, lymph node site). There is significant association between HL, NHL subtypes and (age groups of patients, lymph node site). Conclusion: The most common age group for HL is 11-20 years, while the most common age group for NHL is >60 years. Lymphoma occurs more frequently in the lymph nodes above the diaphragm as well as in patients with HL. The most common age group for NLPHL is 11-20 years and 41-50 years, and most cases occur in the lymph nodes above the diaphragm.